RxSight, Inc. (RXST) Tops Q4 EPS by 20c
Tweet
Share
E-mail
Get Alerts RXST Hot Sheet
Join SI Premium – FREE
RxSight, Inc. (NASDAQ: RXST) reported Q4 EPS of $0.03, $0.20 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $40.2 million versus the consensus estimate of $40.39 million.
For earnings history and earnings-related data on RxSight, Inc. (RXST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
- Deutsche Bank Downgrades Oxford Biomedica (OXB:LN) (OXBDF) to Hold
- Snowflake Inc. (SNOW) PT Raised to $408 at Citizens on Positive Checks
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
